仮性狂犬病ウイルスワクチンの世界市場レポート2020

• 英文タイトル：Global Pseudorabies Virus Vaccine Sales Market Report 2020

• レポートコード：QY20ST-05269 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥560,000 (USD4,000)	▷ お問い合わせ
Multi User	￥840,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,120,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、世界の仮性狂犬病ウイルスワクチン市場について種類別（不活化ワクチン、弱毒化天然ワクチン、遺伝子組換えワクチン）、用途別（政府入札、市場販売）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・仮性狂犬病ウイルスワクチン市場の概要 ・世界の主要地域別仮性狂犬病ウイルスワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の仮性狂犬病ウイルスワクチン市場規模2015-2026：種類別（不活化ワクチン、弱毒化天然ワクチン、遺伝子組換えワクチン） ・世界の仮性狂犬病ウイルスワクチン市場規模2015-2026：用途別（政府入札、市場販売） ・仮性狂犬病ウイルスワクチンの北米市場規模2015-2020 ・仮性狂犬病ウイルスワクチンのヨーロッパ市場規模2015-2020 ・仮性狂犬病ウイルスワクチンの中国市場規模2015-2020 ・仮性狂犬病ウイルスワクチンの日本市場規模2015-2020 ・仮性狂犬病ウイルスワクチンの東南アジア市場規模2015-2020 ・仮性狂犬病ウイルスワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・仮性狂犬病ウイルスワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・仮性狂犬病ウイルスワクチンの市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Pseudorabies Virus Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Pseudorabies Virus Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Porcine pseudorabies is an acute infectious disease of pigs caused by Pseudorabies virus (PrV). The disease is fulminant in pigs. It can cause abortion of pregnant sows, stillbirth, infertility of boars, death of a large number of newborn piglets, difficulty in breathing of fattening pigs, and stagnant growth. It is one of the major infectious diseases that harm the global pig industry.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pseudorabies Virus Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pseudorabies Virus Vaccine industry.
Based on our recent survey, we have several different scenarios about the Pseudorabies Virus Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pseudorabies Virus Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Pseudorabies Virus Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Pseudorabies Virus Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Pseudorabies Virus Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Pseudorabies Virus Vaccine market. The report also includes nautical information, where it shows Pseudorabies Virus Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Pseudorabies Virus Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Pseudorabies Virus Vaccine market.
Geographical Analysis:
Based on region, the global Pseudorabies Virus Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Pseudorabies Virus Vaccine market are
Merck
Merial Limited
Boehringer Ingelheim Animal Health (USA) Co., Ltd.
Zoetis
Hipra
Anhui Divinity Biological Products
Wuhan Keqian Biological Co., Ltd.
China Biotechnology Co., Ltd.
CHINA ANIMAL HUSBANDRY INDUSTRY
Sichuan Huashen
Haley
Tianbang
Dabei Nong
Harvey
Preh Bio
Jiangsu Nannong High-Tech Co.
Guangxi Liyuan Biological Co., Ltd.
Jilin Zhengye Bioengineering Group
Jilin Heyuan Biological Engineering Co., Ltd.
Huapai Biological Engineering Group Co., Ltd.
Beijing Xinde Weite Technology Co., Ltd.
Beijing Veterinary Biopharmaceutical Factory
Qilu Animal Health Products Co., Ltd.
Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
Yunnan Biopharmaceutical Co.
Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
Liaoning Yikang Biological Co., Ltd.
Shanghui Huahong Biological Engineering Co., Ltd.
Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
Segment by Type
Inactivated Vaccine
Naturally Deficient Attenuated Vaccine
Genetic Engineering Vaccine
Segment by Application
Government Tender
Market Sales
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Pseudorabies Virus Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Pseudorabies Virus Vaccine market.
• The market share of the global Pseudorabies Virus Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Pseudorabies Virus Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Pseudorabies Virus Vaccine market.

レポート目次

---

1 Pseudorabies Virus Vaccine Market Overview
1.1 Pseudorabies Virus Vaccine Product Scope
1.2 Pseudorabies Virus Vaccine Segment by Type
1.2.1 Global Pseudorabies Virus Vaccine Sales by Type (2020-2026)
1.2.2 Inactivated Vaccine
1.2.3 Naturally Deficient Attenuated Vaccine
1.2.4 Genetic Engineering Vaccine
1.3 Pseudorabies Virus Vaccine Segment by Application
1.3.1 Global Pseudorabies Virus Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Pseudorabies Virus Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pseudorabies Virus Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Pseudorabies Virus Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Pseudorabies Virus Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Pseudorabies Virus Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Pseudorabies Virus Vaccine Industry
1.5.1.1 Pseudorabies Virus Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Pseudorabies Virus Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Pseudorabies Virus Vaccine Players to Combat Covid-19 Impact

2 Pseudorabies Virus Vaccine Estimate and Forecast by Region
2.1 Global Pseudorabies Virus Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pseudorabies Virus Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pseudorabies Virus Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Pseudorabies Virus Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pseudorabies Virus Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pseudorabies Virus Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pseudorabies Virus Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Pseudorabies Virus Vaccine Estimates and Projections (2015-2026)
2.4.3 China Pseudorabies Virus Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Pseudorabies Virus Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pseudorabies Virus Vaccine Estimates and Projections (2015-2026)
2.4.6 India Pseudorabies Virus Vaccine Estimates and Projections (2015-2026)
3 Global Pseudorabies Virus Vaccine Competition Landscape by Players
3.1 Global Top Pseudorabies Virus Vaccine Players by Sales (2015-2020)
3.2 Global Top Pseudorabies Virus Vaccine Players by Revenue (2015-2020)
3.3 Global Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudorabies Virus Vaccine as of 2019)
3.4 Global Pseudorabies Virus Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Pseudorabies Virus Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pseudorabies Virus Vaccine Players (Opinion Leaders)
4 Global Pseudorabies Virus Vaccine Market Size by Type
4.1 Global Pseudorabies Virus Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Pseudorabies Virus Vaccine Price by Type (2014-2020)
4.2 Global Pseudorabies Virus Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pseudorabies Virus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Pseudorabies Virus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Pseudorabies Virus Vaccine Price Forecast by Type (2021-2026)
5 Global Pseudorabies Virus Vaccine Market Size by Application
5.1 Global Pseudorabies Virus Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Pseudorabies Virus Vaccine Price by Application (2015-2020)
5.2 Global Pseudorabies Virus Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pseudorabies Virus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Pseudorabies Virus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Pseudorabies Virus Vaccine Price Forecast by Application (2021-2026)

3 North America Pseudorabies Virus Vaccine Market Facts & Figures
3.2 North America Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)

4 Europe Pseudorabies Virus Vaccine Market Facts & Figures
4.2 Europe Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)

5 China Pseudorabies Virus Vaccine Market Facts & Figures
5.2 China Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
5.3 China Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
5.4 China Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)

6 Japan Pseudorabies Virus Vaccine Market Facts & Figures
6.2 Japan Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)

7 Southeast Asia Pseudorabies Virus Vaccine Market Facts & Figures
7.2 Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)

8 India Pseudorabies Virus Vaccine Market Facts & Figures
8.2 India Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
8.3 India Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
8.4 India Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Pseudorabies Virus Vaccine Business
12.1 Merck
12.1.1 Merck Pseudorabies Virus Vaccine Corporation Information
12.1.2 Merck Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.1.3 Merck Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Pseudorabies Virus Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 Merial Limited
12.2.1 Merial Limited Pseudorabies Virus Vaccine Corporation Information
12.2.2 Merial Limited Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.2.3 Merial Limited Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merial Limited Pseudorabies Virus Vaccine Products Offered
12.2.5 Merial Limited Recent Development
12.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
12.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.3.5 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Recent Development
12.4 Zoetis
12.4.1 Zoetis Pseudorabies Virus Vaccine Corporation Information
12.4.2 Zoetis Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.4.3 Zoetis Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Zoetis Pseudorabies Virus Vaccine Products Offered
12.4.5 Zoetis Recent Development
12.5 Hipra
12.5.1 Hipra Pseudorabies Virus Vaccine Corporation Information
12.5.2 Hipra Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.5.3 Hipra Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hipra Pseudorabies Virus Vaccine Products Offered
12.5.5 Hipra Recent Development
12.6 Anhui Divinity Biological Products
12.6.1 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Corporation Information
12.6.2 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Products Offered
12.6.5 Anhui Divinity Biological Products Recent Development
12.7 Wuhan Keqian Biological Co., Ltd.
12.7.1 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.7.2 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.7.5 Wuhan Keqian Biological Co., Ltd. Recent Development
12.8 China Biotechnology Co., Ltd.
12.8.1 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.8.2 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.8.5 China Biotechnology Co., Ltd. Recent Development
12.9 CHINA ANIMAL HUSBANDRY INDUSTRY
12.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Corporation Information
12.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Products Offered
12.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Recent Development
12.10 Sichuan Huashen
12.10.1 Sichuan Huashen Pseudorabies Virus Vaccine Corporation Information
12.10.2 Sichuan Huashen Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Products Offered
12.10.5 Sichuan Huashen Recent Development
12.11 Haley
12.11.1 Haley Pseudorabies Virus Vaccine Corporation Information
12.11.2 Haley Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.11.3 Haley Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Haley Pseudorabies Virus Vaccine Products Offered
12.11.5 Haley Recent Development
12.12 Tianbang
12.12.1 Tianbang Pseudorabies Virus Vaccine Corporation Information
12.12.2 Tianbang Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.12.3 Tianbang Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Tianbang Pseudorabies Virus Vaccine Products Offered
12.12.5 Tianbang Recent Development
12.13 Dabei Nong
12.13.1 Dabei Nong Pseudorabies Virus Vaccine Corporation Information
12.13.2 Dabei Nong Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.13.3 Dabei Nong Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Dabei Nong Pseudorabies Virus Vaccine Products Offered
12.13.5 Dabei Nong Recent Development
12.14 Harvey
12.14.1 Harvey Pseudorabies Virus Vaccine Corporation Information
12.14.2 Harvey Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.14.3 Harvey Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Harvey Pseudorabies Virus Vaccine Products Offered
12.14.5 Harvey Recent Development
12.15 Preh Bio
12.15.1 Preh Bio Pseudorabies Virus Vaccine Corporation Information
12.15.2 Preh Bio Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.15.3 Preh Bio Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Preh Bio Pseudorabies Virus Vaccine Products Offered
12.15.5 Preh Bio Recent Development
12.16 Jiangsu Nannong High-Tech Co.
12.16.1 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Corporation Information
12.16.2 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Products Offered
12.16.5 Jiangsu Nannong High-Tech Co. Recent Development
12.17 Guangxi Liyuan Biological Co., Ltd.
12.17.1 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.17.2 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.17.5 Guangxi Liyuan Biological Co., Ltd. Recent Development
12.18 Jilin Zhengye Bioengineering Group
12.18.1 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Corporation Information
12.18.2 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Products Offered
12.18.5 Jilin Zhengye Bioengineering Group Recent Development
12.19 Jilin Heyuan Biological Engineering Co., Ltd.
12.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.19.5 Jilin Heyuan Biological Engineering Co., Ltd. Recent Development
12.20 Huapai Biological Engineering Group Co., Ltd.
12.20.1 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.20.2 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.20.5 Huapai Biological Engineering Group Co., Ltd. Recent Development
12.21 Beijing Xinde Weite Technology Co., Ltd.
12.21.1 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.21.2 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.21.5 Beijing Xinde Weite Technology Co., Ltd. Recent Development
12.22 Beijing Veterinary Biopharmaceutical Factory
12.22.1 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Corporation Information
12.22.2 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Products Offered
12.22.5 Beijing Veterinary Biopharmaceutical Factory Recent Development
12.23 Qilu Animal Health Products Co., Ltd.
12.23.1 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.23.2 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.23.5 Qilu Animal Health Products Co., Ltd. Recent Development
12.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
12.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.24.5 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Recent Development
12.25 Yunnan Biopharmaceutical Co.
12.25.1 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Corporation Information
12.25.2 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Products Offered
12.25.5 Yunnan Biopharmaceutical Co. Recent Development
12.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
12.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Recent Development
12.27 Liaoning Yikang Biological Co., Ltd.
12.27.1 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.27.2 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.27.5 Liaoning Yikang Biological Co., Ltd. Recent Development
12.28 Shanghui Huahong Biological Engineering Co., Ltd.
12.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.28.5 Shanghui Huahong Biological Engineering Co., Ltd. Recent Development
12.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
12.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.29.5 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Recent Development
12.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
12.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Corporation Information
12.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Business Overview and Total Revenue
12.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.30.5 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Recent Development

13 Pseudorabies Virus Vaccine Manufacturing Cost Analysis
13.1 Pseudorabies Virus Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pseudorabies Virus Vaccine
13.4 Pseudorabies Virus Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pseudorabies Virus Vaccine Distributors List
14.3 Pseudorabies Virus Vaccine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Pseudorabies Virus Vaccine Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Pseudorabies Virus Vaccine Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Pseudorabies Virus Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Pseudorabies Virus Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Pseudorabies Virus Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Pseudorabies Virus Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Pseudorabies Virus Vaccine Sales (M Doses) by Region (2015-2020)
Table 10. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Pseudorabies Virus Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Pseudorabies Virus Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Pseudorabies Virus Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Pseudorabies Virus Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Pseudorabies Virus Vaccine (M Doses) of Key Companies (2015-2020)
Table 18. Global Pseudorabies Virus Vaccine Sales Share by Company (2015-2020)
Table 19. Global Pseudorabies Virus Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Pseudorabies Virus Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Pseudorabies Virus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudorabies Virus Vaccine as of 2019)
Table 22. Global Pseudorabies Virus Vaccine Average Price (USD/Doses) of Key Company (2015-2020)
Table 23. Manufacturers Pseudorabies Virus Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Pseudorabies Virus Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Pseudorabies Virus Vaccine Players
Table 27. Global Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 28. Global Pseudorabies Virus Vaccine Sales Share by Type (2015-2020)
Table 29. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Pseudorabies Virus Vaccine Price (M Doses) by Type (2015-2020)
Table 31. Global Pseudorabies Virus Vaccine Sales Share by Type (2021-2026)
Table 32. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Pseudorabies Virus Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Pseudorabies Virus Vaccine Price (M Doses) by Type (2021-2026)
Table 35. Global Pseudorabies Virus Vaccine Sales (M Doses) by Application (2015-2020)
Table 36. Global Pseudorabies Virus Vaccine Sales Share by Application (2015-2020)
Table 37. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Pseudorabies Virus Vaccine Price (M Doses) by Application (2015-2020)
Table 39. Global Pseudorabies Virus Vaccine Sales (M Doses) by Application (2021-2026)
Table 40. Global Pseudorabies Virus Vaccine Sales Share by Application (2021-2026)
Table 41. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Pseudorabies Virus Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Pseudorabies Virus Vaccine Price (M Doses) by Application (2021-2026)
Table 44. United States Pseudorabies Virus Vaccine Sales (M Doses) by Company (2015-2020)
Table 45. United States Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 47. United States Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Pseudorabies Virus Vaccine Sales (M Doses) by Application (2015-2020)
Table 49. United States Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Pseudorabies Virus Vaccine Sales (M Doses) by Company (2015-2020)
Table 51. Europe Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 53. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Pseudorabies Virus Vaccine Sales (M Doses) by Application (2015-2020)
Table 55. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Pseudorabies Virus Vaccine Sales (M Doses) by Company (2015-2020)
Table 57. China Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 59. China Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Pseudorabies Virus Vaccine Sales (M Doses) by Application (2015-2020)
Table 61. China Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Pseudorabies Virus Vaccine Sales (M Doses) by Company (2015-2020)
Table 63. Japan Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 65. Japan Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Pseudorabies Virus Vaccine Sales (M Doses) by Application (2015-2020)
Table 67. Japan Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Pseudorabies Virus Vaccine Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Pseudorabies Virus Vaccine Sales (M Doses) by Company (2015-2020)
Table 75. India Pseudorabies Virus Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Pseudorabies Virus Vaccine Sales (M Doses) by Type (2015-2020)
Table 77. India Pseudorabies Virus Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Pseudorabies Virus Vaccine Sales (M Doses) by Application (2015-2020)
Table 79. India Pseudorabies Virus Vaccine Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 83. Merck Pseudorabies Virus Vaccine Product
Table 84. Merck Recent Development
Table 85. Merial Limited Corporation Information
Table 86. Merial Limited Description and Business Overview
Table 87. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 88. Merial Limited Pseudorabies Virus Vaccine Product
Table 89. Merial Limited Recent Development
Table 90. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporation Information
Table 91. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Description and Business Overview
Table 92. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product
Table 94. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Recent Development
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 98. Zoetis Pseudorabies Virus Vaccine Product
Table 99. Zoetis Recent Development
Table 100. Hipra Corporation Information
Table 101. Hipra Description and Business Overview
Table 102. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 103. Hipra Pseudorabies Virus Vaccine Product
Table 104. Hipra Recent Development
Table 105. Anhui Divinity Biological Products Corporation Information
Table 106. Anhui Divinity Biological Products Description and Business Overview
Table 107. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 108. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product
Table 109. Anhui Divinity Biological Products Recent Development
Table 110. Wuhan Keqian Biological Co., Ltd. Corporation Information
Table 111. Wuhan Keqian Biological Co., Ltd. Description and Business Overview
Table 112. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 113. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product
Table 114. Wuhan Keqian Biological Co., Ltd. Recent Development
Table 115. China Biotechnology Co., Ltd. Corporation Information
Table 116. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 117. China Biotechnology Co., Ltd. Description and Business Overview
Table 118. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product
Table 119. China Biotechnology Co., Ltd. Recent Development
Table 120. CHINA ANIMAL HUSBANDRY INDUSTRY Corporation Information
Table 121. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 122. CHINA ANIMAL HUSBANDRY INDUSTRY Description and Business Overview
Table 123. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product
Table 124. CHINA ANIMAL HUSBANDRY INDUSTRY Recent Development
Table 125. Sichuan Huashen Corporation Information
Table 126. Sichuan Huashen Description and Business Overview
Table 127. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 128. Sichuan Huashen Pseudorabies Virus Vaccine Product
Table 129. Sichuan Huashen Recent Development
Table 130. Haley Corporation Information
Table 131. Haley Description and Business Overview
Table 132. Haley Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 133. Haley Pseudorabies Virus Vaccine Product
Table 134. Haley Recent Development
Table 135. Tianbang Corporation Information
Table 136. Tianbang Description and Business Overview
Table 137. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 138. Tianbang Pseudorabies Virus Vaccine Product
Table 139. Tianbang Recent Development
Table 140. Dabei Nong Corporation Information
Table 141. Dabei Nong Description and Business Overview
Table 142. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 143. Dabei Nong Pseudorabies Virus Vaccine Product
Table 144. Dabei Nong Recent Development
Table 145. Harvey Corporation Information
Table 146. Harvey Description and Business Overview
Table 147. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 148. Harvey Pseudorabies Virus Vaccine Product
Table 149. Harvey Recent Development
Table 150. Preh Bio Corporation Information
Table 151. Preh Bio Description and Business Overview
Table 152. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 153. Preh Bio Pseudorabies Virus Vaccine Product
Table 154. Preh Bio Recent Development
Table 155. Jiangsu Nannong High-Tech Co. Corporation Information
Table 156. Jiangsu Nannong High-Tech Co. Description and Business Overview
Table 157. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 158. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product
Table 159. Jiangsu Nannong High-Tech Co. Recent Development
Table 160. Guangxi Liyuan Biological Co., Ltd. Corporation Information
Table 161. Guangxi Liyuan Biological Co., Ltd. Description and Business Overview
Table 162. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 163. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product
Table 164. Guangxi Liyuan Biological Co., Ltd. Recent Development
Table 165. Jilin Zhengye Bioengineering Group Corporation Information
Table 166. Jilin Zhengye Bioengineering Group Description and Business Overview
Table 167. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 168. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product
Table 169. Jilin Zhengye Bioengineering Group Recent Development
Table 170. Jilin Heyuan Biological Engineering Co., Ltd. Corporation Information
Table 171. Jilin Heyuan Biological Engineering Co., Ltd. Description and Business Overview
Table 172. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 173. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product
Table 174. Jilin Heyuan Biological Engineering Co., Ltd. Recent Development
Table 175. Huapai Biological Engineering Group Co., Ltd. Corporation Information
Table 176. Huapai Biological Engineering Group Co., Ltd. Description and Business Overview
Table 177. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 178. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product
Table 179. Huapai Biological Engineering Group Co., Ltd. Recent Development
Table 180. Beijing Xinde Weite Technology Co., Ltd. Corporation Information
Table 181. Beijing Xinde Weite Technology Co., Ltd. Description and Business Overview
Table 182. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 183. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product
Table 184. Beijing Xinde Weite Technology Co., Ltd. Recent Development
Table 185. Beijing Veterinary Biopharmaceutical Factory Corporation Information
Table 186. Beijing Veterinary Biopharmaceutical Factory Description and Business Overview
Table 187. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 188. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product
Table 189. Beijing Veterinary Biopharmaceutical Factory Recent Development
Table 190. Qilu Animal Health Products Co., Ltd. Corporation Information
Table 191. Qilu Animal Health Products Co., Ltd. Description and Business Overview
Table 192. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 193. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product
Table 194. Qilu Animal Health Products Co., Ltd. Recent Development
Table 195. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporation Information
Table 196. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Description and Business Overview
Table 197. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 198. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 199. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Recent Development
Table 200. Yunnan Biopharmaceutical Co. Corporation Information
Table 201. Yunnan Biopharmaceutical Co. Description and Business Overview
Table 202. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 203. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product
Table 204. Yunnan Biopharmaceutical Co. Recent Development
Table 205. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporation Information
Table 206. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 207. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 208. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 209. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Recent Development
Table 210. Liaoning Yikang Biological Co., Ltd. Corporation Information
Table 211. Liaoning Yikang Biological Co., Ltd. Description and Business Overview
Table 212. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 213. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product
Table 214. Liaoning Yikang Biological Co., Ltd. Recent Development
Table 215. Shanghui Huahong Biological Engineering Co., Ltd. Corporation Information
Table 216. Shanghui Huahong Biological Engineering Co., Ltd. Description and Business Overview
Table 217. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 218. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product
Table 219. Shanghui Huahong Biological Engineering Co., Ltd. Recent Development
Table 220. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporation Information
Table 221. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 222. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table 223. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 224. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Recent Development
Table . Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporation Information
Table . Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table . Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2015-2020)
Table . Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table . Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Recent Development
Table 230. Production Base and Market Concentration Rate of Raw Material
Table 231. Key Suppliers of Raw Materials
Table 232. Pseudorabies Virus Vaccine Distributors List
Table 233. Pseudorabies Virus Vaccine Customers List
Table 234. Market Key Trends
Table 235. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 236. Key Challenges
Table 237. Research Programs/Design for This Report
Table 238. Key Data Information from Secondary Sources
Table 239. Key Data Information from Primary Sources
List of Figures
Figure 1. Pseudorabies Virus Vaccine Product Picture
Figure 2. Global Pseudorabies Virus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pseudorabies Virus Vaccine Market Share by Application in 2020 & 2026
Figure 6. Government Tender Examples
Figure 7. Market Sales Examples
Figure 8. Global Pseudorabies Virus Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Pseudorabies Virus Vaccine Price Trends Growth Rate (2015-2026) (USD/Doses)
Figure 11. Global Pseudorabies Virus Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Pseudorabies Virus Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Pseudorabies Virus Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Pseudorabies Virus Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Pseudorabies Virus Vaccine Players Market Share by Revenue in Pseudorabies Virus Vaccine 2015 & 2019
Figure 26. Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Pseudorabies Virus Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Pseudorabies Virus Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Pseudorabies Virus Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Pseudorabies Virus Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 32. United States Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Pseudorabies Virus Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Pseudorabies Virus Vaccine Sales Market Share by Application in 2019
Figure 36. China Pseudorabies Virus Vaccine Sales Market Share by Company in 2019
Figure 37. China Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 38. China Pseudorabies Virus Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Pseudorabies Virus Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Pseudorabies Virus Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Application in 2019
Figure 45. India Pseudorabies Virus Vaccine Sales Market Share by Company in 2019
Figure 46. India Pseudorabies Virus Vaccine Sales Market Share by Type in 2019
Figure 47. India Pseudorabies Virus Vaccine Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Merial Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Hipra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Anhui Divinity Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Wuhan Keqian Biological Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. China Biotechnology Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CHINA ANIMAL HUSBANDRY INDUSTRY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sichuan Huashen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Haley Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Tianbang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Dabei Nong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Harvey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Preh Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Jiangsu Nannong High-Tech Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Guangxi Liyuan Biological Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Jilin Zhengye Bioengineering Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Jilin Heyuan Biological Engineering Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Huapai Biological Engineering Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Beijing Xinde Weite Technology Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Beijing Veterinary Biopharmaceutical Factory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Qilu Animal Health Products Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Yunnan Biopharmaceutical Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Liaoning Yikang Biological Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. Shanghui Huahong Biological Engineering Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Key Raw Materials Price Trend
Figure 79. Manufacturing Cost Structure of Pseudorabies Virus Vaccine
Figure 80. Manufacturing Process Analysis of Pseudorabies Virus Vaccine
Figure 81. Pseudorabies Virus Vaccine Industrial Chain Analysis
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Porter's Five Forces Analysis
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

---